Created in 2016, Stem Cell Info is an informational resource dedicated to regenerative medicine, research updates, clinical trials, and pharma company developments. Treatment modalities employing stem cell therapy are mostly at the preclinical or clinical trial-stage and have therefore yet to advance to the mass market as standardized therapies. But, a number of biotech companies are in the process of advancing their clinical trial pipelines – and several of them include therapies with blockbuster potential that likely will disrupt certain fields of medicine in the future. However, covering the evolution in the "clinical trial landscape" includes more than just the medical aspect of a new treatment: it includes the competition, the financial position of biotechs, as well as understanding the details of how a clinical trial was conducted. Few details escape our attention and we enjoy sharing what we know: browse our social media newsfeeds or search this website!